recall
saveBoothwyn Pharmacy LLC recall (Cls II)
September 10, 2025updated 5mo ago
community read0 votes
Semaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn Pharmacy — Reason: Subpotent Drug — Status: Ongoing
view source ↗Data sources
last refreshed 17m ago
Found something off?
same company · ±60 days · 6
- recallBoothwyn Pharmacy LLC recall (Cls II)Sep 10, 2025
- recallBoothwyn Pharmacy LLC recall (Cls II)Sep 10, 2025
- approvalWEGOVY (SEMAGLUTIDE) — FDA approvalAug 15, 2025
- approvalWEGOVY (SEMAGLUTIDE) — FDA approvalOct 14, 2025
- approvalOZEMPIC (SEMAGLUTIDE) — FDA approvalOct 14, 2025
- approvalOZEMPIC (SEMAGLUTIDE) — FDA approvalOct 14, 2025
🐶 often sniffed alongside
top 7- companyNovo Nordisk Inc2 co-mentions · 2 sources
- tagHepatology2 co-mentions · 1 sources
- tagObesity2 co-mentions · 1 sources
- tagEndocrinology & Metabolism1 co-mentions · 1 sources
- drugObesity1 co-mentions · 1 sources
- drugzalfermin1 co-mentions · 1 sources
- drugcagrilintide hydrochloride1 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that